Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-controlled Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Pregabalin for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Conditions
Interventions
Pregabalin
Placebo
Locations
11
United States
Charles R Drew University of Medicine & Science
Los Angeles, California, United States
David Geffen School of Medicine at UCLA
Los Angeles, California, United States
Stanford University Medical Center
Stanford, California, United States
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
University of Maryland
Baltimore, Maryland, United States
Harvard Medical School
Boston, Massachusetts, United States
Start Date
March 1, 2006
Primary Completion Date
January 1, 2008
Completion Date
April 30, 2008
Last Updated
September 22, 2025
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions